Insulet recalls insulin pump remote; FDA ranks it as its ‘most serious type’

One of the largest medical device makers in Massachusetts has recalled a remote control for one of its insulin pumps, and the U.S. Food and Drug Administration this week gave the recall its most urgent classification.

Insulet Corp. (Nasdaq: PODD) issued a voluntary recall last month for its Omnipod DASH Insulin Management System’s Personal Diabetes Manager. The device involves two components: a wearable pump that injects insulin into the body; and a battery-powered, smartphone-like remote control…

Previous Visa taps Ryan McInerney to replace Al Kelly as CEO
Next Intermountain Healthcare names new CEO